Fact CheckerSign in

NCT07205783Enrolling by invitation

Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)

Source: ClinicalTrials.gov · Last updated 7 Apr 2026

Brief summary (registry, in English)

In the last few decades not only the diagnosis but also the treatment options for prostate cancer have changed significantly. During this time the surgical procedure of open radical prostatectomy was substantially modified(1,2) and is nowadays considered a safe procedure providing high cancer control rates with low morbidity.(3) The main goal of radical prostatectomy regardless of the approach remains the eradication of cancer while preserving pelvic organ function,whenever possible.(4)

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
40 (estimated)
First submitted
26 Sept 2025
Start date
14 Sept 2022
Primary completion date
14 Sept 2026
Lead sponsor
Sohag University
NCT number
NCT07205783

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 14 Sept 2022 to the primary completion date, 14 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • coagulopathy. Pulmonary diseases metastatic tumor

Who the study is looking for

  • Cancer prostate: confirmed by prostate biopsy Cancer stage: T2,T3

Age in the registry: 40 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sohag University
Coordinator of this site? Confirm its status
SohagEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.